Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05103345
Title Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Guangzhou Sinogen Pharmaceutical Co., Ltd
Age Groups: senior | adult
Covered Countries

No variant requirements are available.